CD8 is one of several cell surface glycoproteins implicated in various T cell activation and effector functions. The subset of T cells that express CD8 are restricted in their antigen recognition by class I MHC molecules (1-3). The participation of CD8 in MHC-restricted antigen recognition by T cells was suggested by findings from several groups that anti-CD8 antibodies inhibited T cell antigen recognition (4-11) . This inhibition was attributed to antibody-mediated interference with the binding of CD8 to its ligand, thought to be nonpolymorphic determinants on class I MHC molecules. However, recent experiments have indicated that anti-CD8 antibodies may block T cell function by transducing a negative signal to the effector T cell (12-16), an observation that has necessitated a reinterpretation of earlier antibody blocking data . In view ofthe complexities of anti-CD8 antibody blocking studies, alternative approaches are required to define the function of CD8.
CD8 is one of several cell surface glycoproteins implicated in various T cell activation and effector functions. The subset of T cells that express CD8 are restricted in their antigen recognition by class I MHC molecules (1) (2) (3) . The participation of CD8 in MHC-restricted antigen recognition by T cells was suggested by findings from several groups that anti-CD8 antibodies inhibited T cell antigen recognition (4) (5) (6) (7) (8) (9) (10) (11) . This inhibition was attributed to antibody-mediated interference with the binding of CD8 to its ligand, thought to be nonpolymorphic determinants on class I MHC molecules. However, recent experiments have indicated that anti-CD8 antibodies may block T cell function by transducing a negative signal to the effector T cell (12) (13) (14) (15) (16) , an observation that has necessitated a reinterpretation of earlier antibody blocking data . In view ofthe complexities of anti-CD8 antibody blocking studies, alternative approaches are required to define the function of CD8.
Gene transfer technology offers a more direct approach for characterizing the function of T cell surface molecules. In two independent transfection studies of CD8 (17) (18) (19) , reconstitution ofantigen specificity and class I MHC restriction was achieved in murine CD8 -T cell hybridomas by stable transfer of the genes encoding CD8 and the TCR a and R chains . The use of T cell hybridomas in these studies limited the number of functions that could be evaluated. Transfection studies with human T cell clones are advantageous because they allow for a more complete range offunctional responses to be assessed .
In a recent study, we have linked anti-sense RNA mutagenesis and human T cell cloning technologies . Specifically, we demonstrated that surface expression of CD8 was selectively inhibited by >95% using an EBV episome-based anti-sense RNA expression system (20) . The antigen specificity of the T cell clone used in that study was unknown, and therefore, effects on antigen recognition could not be assessed . In this report, we describe the functional consequences of inhibiting CD8 expression in a human T cell clone with known antigenic specificity.
This work was supported in part by grants R29 CA-47566 andP30 CA-43703 from the National Cancer Institute, grant ROl AI-22505 from the National Institute of Allergy and Infectious Diseases, grant ROl AA-07385 from the National Institute on Alcohol Abuse and Alcoholism, and a salary support (24) . Briefly, IL-2 secretion was induced by incubating an equal number of JH .ARL .1 cells (10 6 cells/ml; 11 d post-anti-CD3 stimulation) with irradiated LCL cells for 18 h at 37°C and 7% C02 . The supernatants from these cultures were collected and assayed for IL-2 activity using a cloned human T cell line ( brighter than the cells stained with control IgG . For the a-CD8/REPI-transfected cells, the anti-CD8 peak was less then two times more intense than the control peak . (20), and they demonstrate that efficient and selective inhibition of CD8 expression can be obtained in T cell clones using an EBV episomebased expression system . Requirement for CD8 in Alloantigen-specific Cytotoxicity by JH.ARL .1 . The effects on T cell function of selectively inhibiting cell surface CD8 expression were investigated . The ability of the a-CD8/REP1 transfectant to mediate lysis of antigen-specific, antigen-nonspecific, and lectin-coated targets was determined using a standard "Crrelease assay (Fig . 2) . Lysis of an antigen-specific target (AR.LCL) by the a-CD8/ REPI transfectant was inhibited at all E/T ratios examined in comparison with lysis by nontransfected JH .ARL .1 cells or the RSVCATa/220.2 transfectant . Even at the highest E/T ratio (20:1), antigen-specific cytotoxicity mediated by the a-CD8/REPI transfectant was less than that mediated by controls at an E/T ratio of 2.5 :1 . None of the effector cells were capable of killing a nonspecific target (DK.LCL ; HLA-B35-), demonstrating that cytotoxicity was not inappropriately expressed in the transfected cell lines. To determine whether the cytotoxic machinery of JH .ARL .1 was affected by loss of CD8 surface expression, we studied lectin-dependent cytotoxicity. The parental cloned line and both transfectants could efficiently lyse lectincoated targets (PHA-coated K562). Thus, anti-sense RNA-mediated inhibition of CD8 expression in an antigen-specific T cell clone markedly inhibited lysis of antigenspecific targets without affecting lectin-mediated killing.
Since cytolytic activity requires conjugate formation between effector and target cells, we next examined the ability of a-CD8/REP1 transfectant cells to form conjugates. Inhibition of CD8 expression on theJH .ARL .1 clone did not affect the ability of these cells to conjugate with either HLA-1135+ or HLA-1135 -cells (data not shown) . This result suggests that the inhibition of antigen-specific cytotoxicity in the CD8-variant is not explained by interference with the initial nonspecific adhesion events (25, 26) Cr and used as targets in a standard 4-h 5 'Cr-release assay. Effector cells (nontransfected JH .ARL .1, " ; the RSVCATa/220.2 transfectant, / ; the a-CD8/REPI transfectant, A) were used at various E/T ratios. PHA was included in assays with K562 targets. creased expression of CD8 inhibits antigen-specific recongnition of a class I MHC product.
Role of CD8 inAlloantigen-triggered Proliferation. Another event associated with TCRtransduced antigen-specific recognition is proliferation. The ability of the a-CD8/ REP1 transfectant to proliferate in response to stimulation by irradiated LCL cells, irradiated PBMC, and anti-CD3 mAbs, or irradiated PBMC and PHA was assessed using a [3H]thymidine incorporation assay (Table I) . Whereas nontransfected JH.ARL.1 cells and the RSVCATa/220.2 transfectant proliferated in response to stimulation by AR.LCL cells (HLA-B35' ), the proliferative response of the a-CD8/ REP1 transfectant to stimulation by AR.LCL was significantly decreased. This decrease was still evident even with exogenous IL-2 added to the culture. In contrast to the marked decrease in antigen-specific stimulation, anti-CD3-or PHA-mediated proliferative responses were unaffected in the a-CD8/REP1 transfectant . This result demonstrates that inhibition ofCD8 expression on an alloantigen-specific T cell clone decreases its ability to proliferate in response to alloantigenic stimulation without affecting proliferation induced by stimuli that do not involve antigenic recognition (anti-CD3 or PHA plus PBMC).
Since proliferation of T cell clones is mediated by IL-2 and is dependent upon induction of IL-2-R expression, we measured IL-2 secretion (Table II) Supernatants were harvested after incubation for 18 h and assayed for IL-2 activity on an IL-2-dependent indicator cell line . SD of means >I,000 dpm were <10% of the means and have been omitted . Background level of thymidine incorporation was 210 dpm, and optimal responses at 2 .5 U/ml of rIL-2 was 8,986 dpm . AR .LCL is the specific target for JH .ARL .1, and DK .LCL is an unrelated cell line .
stimulated responses, including secretion of the lymphokine IL-2 and acquisition of IL-2-R, on the expression of the surface molecule CD8.
Discussion
We have used an anti-sense CD8 episomal expression construct to derive a CD8-variant of an allospecific, nontransformed human T cell clone. This stably transfected clone was markedly inhibited in a number of T cell functional responses to alloantigenic stimulaton, including cytotoxicity, proliferation, lymphokine secretion, and lymphokine receptor expression . In contrast to TCRdependent activation, this CD8 -T cell variant could still mediate functions elicited by lectin or anti-CD3 .
CD8 on T cells is thought to directly bind to class I MHC products on target cells (27, 28) in a fashion analogous to the direct binding of CD4 to class II MHC products (29) . Along with this trans interaction, CD8 is postulated to associate in a cis interaction with the TCR/CD3 complex on the same T cell . The TCR/CD3 complex and CD8 have been shown to comodulate from the cell surface after specific antigenic stimulation (30, 31) . By decreasing surface expression of CD8, we have eliminated the interactions that are essential for optimal activation of T cell functional responses requiring antigen recognition through the TCR/CD3 complex.
Previous findings that anti-CD8 antibodies inhibit anti-CD3-or lectin-mediated cytotoxic and proliferative responses of CD8 + clones have suggested that a negative signal transduction event occurs by perturbation of surface CD8 or that anti-CD8 inhibits positive signal transduction (12) (13) (14) (15) (16) . Our data do not directly address this important issue, but it is interesting to note that marked inhibition of CD8 surface expression did not either positively or negatively affect effector functions elicited by anti-CD3 or lectin for two distinct human T cell clones, 8L2 (20) and JH .ARL .1 . If signal transduction via CD8 is significant in the absence of the addition of anti-CD8 mAbs, some alteration would be expected in the CD8-variants in anti-CD3 or lectin-mediated responses. To date we have not found any evidence for this type of alteration .
The finding that conjugation was not altered by the loss of surface CD8 suggests that effects on conjugation do not explain the observed functional defects in the CD8 -variant. Studies of the effects of anti-CD8 mAbs on conjugate formation have reported contradictory results (5, 23, (32) (33) (34) . Our findings using mutational analysis demonstrate that CD8 is not necessary for nonspecific conjugation, an interaction that is presumably mediated by LFA-1/ICAM-1 and CD2/LFA-3 ligand-receptor pairs (35, 36) . In no case were the functional deficits in the CD8-variant reduced to background levels . This finding might be explained by the presence of residual surface CD8, or alternatively, there could be a low level of non-CD8-dependent stimulation occurring in the antigen-specific functional assays that could be mediated by the TCR alone. Nonetheless, it is clear that a >97% decrease in CD8 surface expression dramatically inhibited antigenic stimulation of all of the effector functions tested .
We have developed an alternative approach for defining the function of T cell molecules by applying anti-sense RNA mutagenesis to the analysis of human T cell clones . The use of a nontransformed human T cell clone has allowed us to assess an array of functions requiring antigen-specific recognition that could not be assessed with murine hybridomas . Our procedure does not require the use of exogenous antibodies, thereby obviating the difficulties in interpretation of such studies. The transfection of anti-sense expression vectors into human T cell clones represents a different approach for analyzing the functions of T cell surface molecules. In this case, we have demonstrated that CD8 is necessary for antigen recognition of a class I MHC product by an allogeneic human T cell clone.
Summary
An experimental approach for defining the function of CD8 has been developed by linking anti-sense RNA mutagenesis and T cell cloning technologies . We have transfected an anti-sense CD8 episomal expression vector into a CD8+ nontransformed human T cell clone that is specific for the human class I alloantigen HLA-B35. Expression of CD8 on this T cell clone, JH .ARL .1, was selectively and efficiently inhibited. Stimulation of this CD8 -variant with specific alloantigen resulted in a marked loss of a number of functional responses, including cytotoxicity, proliferation, IL-2 secretion, and IL-2-R expression. However, these same functional responses could be elicited with stimuli that do not require antigen recognition to activate the T cell (anti-CD3 mAbs, PHA) . The results of our study support the hypothesis that CD8 is required for recognition of class I MHC alloantigens that results in activation of T cell functional responses.
